Spero Therapeutics logo
Healthcare & Life Sciences

Spero Therapeutics

Spero Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.

Activeseed
seed
Stage
2014
Founded
1
Investors

About Spero Therapeutics

Based in the United States, Spero Therapeutics is a startup founded in 2014. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Spero Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines for immune-mediated diseases and rare infections, including investigational therapies such as SP001 for IgG4-related disease and tebipenem pivoxil for complicated urinary tract infections.

Explore Spero Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States